Share this article
Share this article
ResearchAndMarkets.com s offering.
Over the past few years, the idea of immunotherapy of ability to manipulate immune cells in targeting tumor cells is gaining momentum in field of cancer therapeutics. Since then scientists have developed a wide range of potential candidates which has shown encouraging results in the management of cancer.
The recent clinical success of chimeric antigen receptor in the management of hematological malignancies has clearly led to the explosion in the field of adoptive cell therapy for cancer. Researchers are currently putting efforts for the translation of this exciting technology in solid tumors and the development of allogeneic off the shelf therapies.
Asian Markets Mostly Lower
CANBERA (dpa-AFX) - Asian stock markets are mostly lower on Wednesday following mixed lead overnight from Wall Street as investors stayed cautious as they looked ahead to the Federal Reserve s monetary policy announcement. They are also looking for central bank s forecasts for the economy, inflation and interest rates. Asian markets closed mostly higher on Tuesday.
The Australian stock market is declining on Wednesday, with the benchmark S&P/ASX 200 below the 6,800 level, after three straight sessions of gains, following inconclusive cues overnight from Wall Street as investors stayed cautious while they look ahead to the Federal Reserve s policy announcement. Gains in the technology stocks were more than offset by weakness in materials and energy stocks amid weak commodity prices.
Japanese Market Extending Gains Into Seventh Day
TOKYO (dpa-AFX) - The Japanese stock market is rising after early losses on Wednesday, with the benchmark Nikkei index moved above the 29,900 level, following inconclusive cues overnight from Wall Street as investors stayed cautious while they await Federal Reserve s policy announcement.
The benchmark Nikkei 225 Index is gaining 38.05 points or 0.13 percent to 29,959.14, after touching a low of 29,825.16 in early trades. Japanese stocks closed higher on Tuesday.
Market heavyweight SoftBank Group is declining more than 1 percent, while Uniqlo operator Fast Retailing is up almost 1 percent. Among automakers, Honda is losing more than 1 percent and Toyota is down almost 1 percent.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global analgesics market is expected to grow from $68.2 billion in 2019 to $78.1 billion in 2020 at a compound annual growth rate (CAGR) of 14.7%.
This growth is mainly due to the COVID-19 outbreak and the neuroinvasive nature of the virus. The CNS is more prone to the viral infection. The virus affects the senses of smell and taste and therefore it is important to curb the interaction between the viral protein and the human receptor, and this factor is driving the demand for CNS drugs. The market is then expected to grow at a CAGR of 5.5% from 2021 and reach $91 billion in 2023.